United Kingdom · Question · Written question
UIN 56074
Blood Cancer: Medical Treatments
Original
Introduced
8 June 2020
Last action
1 July 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
1 July 2020
Summary
To ask the Secretary of State for Health and Social Care, what treatment options are available to patients with multiple myeloma who have become refractory to previous lines of therapy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 June 2020
Written question
To ask the Secretary of State for Health and Social Care, what treatment options are available to patients with multiple myeloma who have become refractory to previous lines of therapy.
Source: Commons
1 July 2020
Answer
For patients who have received previous lines of treatment, the National Institute for Health and Care Excellence (NICE) currently recommends the following subsequent treatments in England:- Daratumumab with bortezomib and dexamethasone (NICE TA573);- Car...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-06-08/56074
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1201409
- uk · wq-1201409 · source updated 1 July 2020